- Imitrex oral Uses, Side Effects, Interactions, Pictures. - WebMD
- Viagra And Imitrex Official Online pharmacy
- Imitrex Injection Sumatriptan Succinate Injection Drug. - RxList
- Imitrex Intranasal, Onzetra Xsail sumatriptan intranasal dosing.
Imitrex oral Uses, Side Effects, Interactions, Pictures. - WebMD
Imitrex (sumatriptan) is a headache medicine that narrows blood vessels around the brain.
Viagra And Imitrex Official Online pharmacy
Although many nasal sprays are intended to be administered in each nostril for a single dose, there are notable exceptions.
Imitrex Injection Sumatriptan Succinate Injection Drug. - RxList
Teva's generic medications are available in most pharmacies across the United States, though not all pharmacies carry the same Teva medications.
Imitrex Intranasal, Onzetra Xsail sumatriptan intranasal dosing.
Atypical Sensations: Tingling, numbness, pressure sensation, cold sensation, feeling of thtness Cardiovascular: Flushing, hypertension, palpations, tachycardia, arrhythmia, edema Chest thtness/discomfort, chest pressure/heaviness Disturbance of hearing, ear infections Eye irritation and visual disturbances Gastrointestinal: Abdominal discomfort, diarrhea, dysphagia, GERD, dry mouth, thirst Musculoskeletal: Neck pain/stiffness, backache, weakness, joint symptoms, arthritis, myalgia, muscle cramps Neurological: Drowsiness/sedation, anxiety, sleep disturbances, tremors, syncope, chills, depression, agitation, confusion Respiratory: Dyspnea, lower respiratory infection Skin: Rash/skin eruption, pruritus, erythema Urogenital: Dysuria, dysmenorrhea Blood: Hemolytic anemia, pancytopenia, thrombocytopenia Cardiovascular: Atrial fibrillation, cardiomyopathy, colonic ischemia, Prinzmetal variant angina, pulmonary embolism, shock, thrombopebitis Ear, nose, throat: Deafness Eye: Ischemic optic neuropathy, retinal artery occlusion, retinal vein thrombosis, loss of vision Gastrointestinal: Ischemic colitis, dry mouth Hepatic: Elevated LFTs Neurological: CNS vasculitis, cerebrovascular accident, dysphasia, serotonin syndrome, subarachnoid hemorrhage Psychiatric: Panic disorder Respiratory: bronchospasm in patients with or without a history of asthma Skin: exacerbation of sunburn, hypersensitivity reactions (erythema, pruritus, rash), photosensitivity Urogenital: acute renal failure Nonspecific: Angioneurotic edema, cyanosis, death, temporal arteritis Current/history of: ischemic cardiac, cerebrovascular, or peripheral vascular syndromes (angina, MI, stroke, TIA, ischemic bowel disease) Uncontrolled hypertension Coadministration of MAO-A inhibitors or use within 2 weeks after discontinuing MAO-A inhibitors Use within 24 hr of any ergotamine-containing or ergot-type medication (eg, dihydroergotamine or methysergide) Use within 24 hr of other 5-HT1 agonists Hypersensitivity Severe hepatic impairment Not indicated for basilar or hemiplegic mraine Clear diagnosis of mraine headache has been established Overuse of acute mraine drugs (eg, ergotamine, triptans, opioids, or combination of these drugs for ≥10 days/month) may lead to exacerbation of headache (medication overuse headache) Serious cardiac and cerebrovascular events, including cerebral hemorrhage, subarachnoid hemorrhage, stroke, acute MI, arrhythmias, and death reported within a few hours after administration Chest discomfort and jaw or neck thtness reported infrequently following intranasal administration (relatively common following SC injection) Not for use with unrecognized CAD as predicted by risk factors (eg, hypertension, hypercholesterolemia, smoking, obesity, diabetes, strong family history of CAD, female with surgical or physiological menopause, male aged 40 yr) Serotonin syndrome may occur, particularly when coadministered with SSRIs (eg, fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram) or SNRIs (eg, venlafaxine, duloxetine) Increased blood pressure, including hypertensive crisis reported (rare) Local irritation of nose and throat reported Pregnancy Category: C Reproductive toxicity studies for sumatriptan by intranasal route have not been conducted; embryolethality and blood vessel abnormalities observed with PO or IV doses in pregnant rabbits during organogenesis Lactation: Excreted in human breast milk in very low levels (NLM Toxnet); minimize infant to potential exposure by avoiding breastfeeding for 8-12 hr after administration The above information is provided for general informational and educational purposes only.
Rating: 100 / 100
Overall: 88 Rates